{"id":"https://openalex.org/W320651567","doi":null,"title":"Future Directions for Pharmaceutical Policy in the New Era of High Cost Medicines","display_name":"Future Directions for Pharmaceutical Policy in the New Era of High Cost Medicines","publication_year":2012,"publication_date":"2012-12-01","ids":{"openalex":"https://openalex.org/W320651567","mag":"320651567"},"language":"en","primary_location":{"id":"mag:320651567","doi":null,"is_oa":false,"landing_page_url":"http://repository.kihasa.re.kr/bitstream/201002/8684/1/working%20paper_2012-04.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4306464556","display_name":"\ud55c\uad6d\ubcf4\uac74\uc0ac\ud68c\uc5f0\uad6c\uc6d0 eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\ud55c\uad6d\ubcf4\uac74\uc0ac\ud68c\uc5f0\uad6c\uc6d0 eBooks","raw_type":null},"volume":null,"type":"book","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068721568","display_name":"Sylvia Park","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sylvia Park","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5084241236","display_name":"Eun\u2010Ja Park","orcid":"https://orcid.org/0000-0001-5465-8674","observed_orcids":["https://orcid.org/0000-0001-5465-8674"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eun\u2010Ja Park","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5465-8674","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11531","display_name":"Healthcare Systems and Reforms","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/high-cost-drugs","display_name":"high-cost medicines","score":0.9850000143051147},{"id":"https://openalex.org/keywords/pharmaceutical-policy","display_name":"pharmaceutical policy","score":0.9909999966621399},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.796999990940094},{"id":"https://openalex.org/keywords/drug-market","display_name":"drug market","score":0.5389999747276306},{"id":"https://openalex.org/keywords/insurance-coverage","display_name":"insurance coverage","score":0.796999990940094},{"id":"https://openalex.org/keywords/evidence-generation","display_name":"evidence generation","score":0.8980000019073486},{"id":"https://openalex.org/keywords/health-insurance","display_name":"health insurance","score":0.5009999871253967},{"id":"https://openalex.org/keywords/korea","display_name":"Korea","score":0.37400001287460327}],"concepts":[{"id":"https://openalex.org/C2780129039","wikidata":"https://www.wikidata.org/wiki/Q1931107","display_name":"Section (typography)","level":2,"score":0.8998055458068848},{"id":"https://openalex.org/C48103436","wikidata":"https://www.wikidata.org/wiki/Q599031","display_name":"State (computer science)","level":2,"score":0.4336038827896118},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.3568267524242401},{"id":"https://openalex.org/C162118730","wikidata":"https://www.wikidata.org/wiki/Q1128453","display_name":"Actuarial science","level":1,"score":0.3222059905529022},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.2570400834083557},{"id":"https://openalex.org/C112698675","wikidata":"https://www.wikidata.org/wiki/Q37038","display_name":"Advertising","level":1,"score":0.09798914194107056},{"id":"https://openalex.org/C11413529","wikidata":"https://www.wikidata.org/wiki/Q8366","display_name":"Algorithm","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:320651567","doi":null,"is_oa":false,"landing_page_url":"http://repository.kihasa.re.kr/bitstream/201002/8684/1/working%20paper_2012-04.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4306464556","display_name":"\ud55c\uad6d\ubcf4\uac74\uc0ac\ud68c\uc5f0\uad6c\uc6d0 eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\ud55c\uad6d\ubcf4\uac74\uc0ac\ud68c\uc5f0\uad6c\uc6d0 eBooks","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":3,"referenced_works":["https://openalex.org/W1974435973","https://openalex.org/W2065290463","https://openalex.org/W2083585578"],"related_works":["https://openalex.org/W2776951691","https://openalex.org/W4390610100","https://openalex.org/W1867572908","https://openalex.org/W4388454109","https://openalex.org/W4390229368","https://openalex.org/W2955813796","https://openalex.org/W1992093714","https://openalex.org/W2268504931","https://openalex.org/W2919379122","https://openalex.org/W3110701574"],"abstract_inverted_index":{"CHAPTER":[0],"1":[1],"\nIntroduction":[2],"3\nSection":[3,6],"1.":[4,22,61,80],"Background":[5],"2.":[7,28,67,84],"Purpose":[8],"4\nSection":[9],"3.":[10,34,88],"Contents":[11],"and":[12,41,55],"Methods":[13],"4\n\nCHAPTER":[14],"2":[15],"\nCurrent":[16],"State":[17,36],"of":[18,24,30,37],"high-cost":[19,49],"medicines":[20,50],"9\nSection":[21,27],"Definition":[23],"High-Cost":[25,31,38,62,76],"Medicines":[26,32,54,63],"Characteristics":[29],"13\nSection":[33],"Current":[35],"Drug":[39,77],"Market":[40],"Outlook":[42],"16\nSection":[43],"4.":[44],"Policy":[45],"Issues":[46],"Related":[47],"to":[48],"20\n\nCHAPTER":[51],"3":[52],"\nHigh-Cost":[53],"Relevant":[56,68],"Systems":[57,69],"in":[58,64,74],"Korea":[59,65],"29\nSection":[60],"33\nSection":[66],"36\n\nCHAPTER":[70],"4":[71],"\nPolicy":[72],"Recommendations":[73],"the":[75],"Era":[78],"55\nSection":[79],"Insurance":[81],"Coverage":[82],"49\nSection":[83],"Appropriate":[85],"Utilization":[86],"51\nSection":[87],"Enhanced":[89],"Evidence":[90],"Development":[91],"54\n\nCHAPTER":[92],"5":[93],"\nConclusions":[94],"61\n\nReferences":[95],"61":[96]},"counts_by_year":[{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2016-06-24T00:00:00"}